about
A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 DiabetesPemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)Effectiveness of V-Go™ for Patients With Diabetes in a Real-world SettingPhase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
P6153
description
US-amerikanische Organisation
@de
organisatie uit Verenigde Staten van Amerika
@nl
other organization in Chattanooga, United States
@en
منظمة في تشاتانوغا، الولايات المتحدة
@ar
name
University Diabetes and Endocrine Consultants
@en
type
label
University Diabetes and Endocrine Consultants
@en
prefLabel
University Diabetes and Endocrine Consultants
@en
P131
P2427
grid.478066.b
P31
P625
Point (-85.215714 35.010917)